These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 32185722)

  • 1. Exosome and Secretion: Action On?
    Hu Y; Zhang R; Chen G
    Adv Exp Med Biol; 2020; 1248():455-483. PubMed ID: 32185722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.
    Morrissey SM; Yan J
    Trends Cancer; 2020 Jul; 6(7):550-558. PubMed ID: 32610067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome mediated communication within the tumor microenvironment.
    Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
    J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of exosomal PD-L1 in tumor progression and immunotherapy.
    Xie F; Xu M; Lu J; Mao L; Wang S
    Mol Cancer; 2019 Oct; 18(1):146. PubMed ID: 31647023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
    Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
    Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.
    Czernek L; Düchler M
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):311-323. PubMed ID: 28101591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Detection of Exosomal PD-L1 in Peripheral Blood.
    Wang R; Yang Y; Huang J; Yao Y
    Methods Mol Biol; 2023; 2695():195-212. PubMed ID: 37450120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments.
    Shenoy GN; Bhatta M; Bankert RB
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-Mediated Immunosuppression in Tumor Microenvironments.
    Xie QH; Zheng JQ; Ding JY; Wu YF; Liu L; Yu ZL; Chen G
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of exosome-derived noncoding RNAs in the tumor immune microenvironment and their future applications.
    Wei F; Li Y
    Biomed Pharmacother; 2022 Dec; 156():113863. PubMed ID: 36244268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer.
    Tang Y; Zhang P; Wang Y; Wang J; Su M; Wang Y; Zhou L; Zhou J; Xiong W; Zeng Z; Zhou Y; Nie S; Liao Q
    Front Immunol; 2020; 11():604. PubMed ID: 32322256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miRNAs assist in the crosstalk between tumor cells and immune cells and its potential therapeutics.
    Chen X; Li Y; Li M; Xie Y; Wang K; Zhang L; Zou Z; Xiong L
    Life Sci; 2023 Sep; 329():121934. PubMed ID: 37460057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of PD-L1
    Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
    Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived exosomal PD-L1 in progression of cancer and immunotherapy.
    Rasihashemi SZ; Rezazadeh Gavgani E; Majidazar R; Seraji P; Oladghaffari M; Kazemi T; Lotfinejad P
    J Cell Physiol; 2022 Mar; 237(3):1648-1660. PubMed ID: 34825383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Escape Mediated by Exosomal PD-L1 in Cancer.
    Lawler SE; Nowicki MO; Ricklefs FL; Chiocca EA
    Adv Biosyst; 2020 Dec; 4(12):e2000017. PubMed ID: 32383351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
    Santos P; Almeida F
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression.
    Shojaei S; Hashemi SM; Ghanbarian H; Salehi M; Mohammadi-Yeganeh S
    J Cell Physiol; 2019 Apr; 234(4):3394-3409. PubMed ID: 30362503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
    Whiteside TL
    Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.